These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21309615)

  • 1. Sample size and power for cost-effectiveness analysis (part 1).
    Glick HA
    Pharmacoeconomics; 2011 Mar; 29(3):189-98. PubMed ID: 21309615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power and sample assessments for tests of hypotheses on cost-effectiveness ratios.
    Gardiner JC; Huebner M; Jetton J; Bradley CJ
    Health Econ; 2000 Apr; 9(3):227-34. PubMed ID: 10790701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power and sample size for cost-effectiveness analysis: fFN neonatal screening.
    Boyd KA; Briggs AH; Fenwick E; Norrie J; Stock S
    Contemp Clin Trials; 2011 Nov; 32(6):893-901. PubMed ID: 21782976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculation for a stepped wedge trial.
    Baio G; Copas A; Ambler G; Hargreaves J; Beard E; Omar RZ
    Trials; 2015 Aug; 16():354. PubMed ID: 26282553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size and power for cost-effectiveness analysis (Part 2): the effect of maximum willingness to pay.
    Glick HA
    Pharmacoeconomics; 2011 Apr; 29(4):287-96. PubMed ID: 21395349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement?
    Wong MY; Day NE; Luan JA; Chan KP; Wareham NJ
    Int J Epidemiol; 2003 Feb; 32(1):51-7. PubMed ID: 12690008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
    Manju MA; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.
    Sahai H; Khurshid A
    Stat Med; 1996 Jan; 15(1):1-21. PubMed ID: 8614740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation, power and sample size calculations for stochastic cost and effectiveness analysis.
    Walter SD; Gafni A; Birch S
    Pharmacoeconomics; 2007; 25(6):455-66. PubMed ID: 17523751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of large numbers of hypothesis tests on power, effect size and sample size.
    Lazzeroni LC; Ray A
    Mol Psychiatry; 2012 Jan; 17(1):108-14. PubMed ID: 21060308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.
    Willan AR; O'Brien BJ
    Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Markov model for sample size calculation and inference in vaccine cost-effectiveness studies.
    Byrnes GB
    Stat Med; 2002 Nov; 21(21):3249-60. PubMed ID: 12375302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis, sample size, and power for estimating incremental net health benefit from clinical trial data.
    Willan AR
    Control Clin Trials; 2001 Jun; 22(3):228-37. PubMed ID: 11384787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A myriad of methods: calculated sample size for two proportions was dependent on the choice of sample size formula and software.
    Bell ML; Teixeira-Pinto A; McKenzie JE; Olivier J
    J Clin Epidemiol; 2014 May; 67(5):601-5. PubMed ID: 24439070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal sample sizes for Welch's test under various allocation and cost considerations.
    Jan SL; Shieh G
    Behav Res Methods; 2011 Dec; 43(4):1014-22. PubMed ID: 21512873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple, defensible sample sizes based on cost efficiency.
    Bacchetti P; McCulloch CE; Segal MR
    Biometrics; 2008 Jun; 64(2):577-85; discussion 586-94. PubMed ID: 18482055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics notes: cost effectiveness calculations and sample size.
    Torgerson DJ; Campbell MK
    BMJ; 2000 Sep; 321(7262):697. PubMed ID: 10987781
    [No Abstract]   [Full Text] [Related]  

  • 20. Power and sample size calculations. A review and computer program.
    Dupont WD; Plummer WD
    Control Clin Trials; 1990 Apr; 11(2):116-28. PubMed ID: 2161310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.